• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Virol . Coronavirus discovery by metagenomic sequencing: a tool for pandemic preparedness

tetano

Editor, Senior Moderator
J Clin Virol


. 2020 Aug 21;131:104594.
doi: 10.1016/j.jcv.2020.104594. Online ahead of print.
Coronavirus discovery by metagenomic sequencing: a tool for pandemic preparedness


Ellen C Carbo[SUP] 1 [/SUP], Igor A Sidorov[SUP] 2 [/SUP], Jessika C Zevenhoven-Dobbe[SUP] 2 [/SUP], Eric J Snijder[SUP] 2 [/SUP], Eric C Claas[SUP] 2 [/SUP], Jeroen F J Laros[SUP] 3 [/SUP], Aloys C M Kroes[SUP] 2 [/SUP], Jutte J C de Vries[SUP] 2 [/SUP]



Affiliations

Abstract

Introduction: The SARS-CoV-2 pandemic of 2020 is a prime example of the omnipresent threat of emerging viruses that can infect humans. A protocol for the identification of novel coronaviruses by viral metagenomic sequencing in diagnostic laboratories may contribute to pandemic preparedness.
Aim: The aim of this study is to validate a metagenomic virus discovery protocol as a tool for coronavirus pandemic preparedness.
Methods: The performance of a viral metagenomic protocol in a clinical setting for the identification of novel coronaviruses was tested using clinical samples containing SARS-CoV-2, SARS-CoV, and MERS-CoV, in combination with databases generated to contain only viruses of before the discovery dates of these coronaviruses, to mimic virus discovery.
Results: Classification of NGS reads using Centrifuge and Genome Detective resulted in assignment of the reads to the closest relatives of the emerging coronaviruses. Low nucleotide and amino acid identity (81% and 84%, respectively, for SARS-CoV-2) in combination with up to 98% genome coverage were indicative for a related, novel coronavirus. Capture probes targeting vertebrate viruses, designed in 2015, enhanced both sequencing depth and coverage of the SARS-CoV-2 genome, the latter increasing from 71% to 98%.
Conclusion: The model used for simulation of virus discovery enabled validation of the metagenomic sequencing protocol. The metagenomic protocol with virus probes designed before the pandemic, can assist the detection and identification of novel coronaviruses directly in clinical samples.

Keywords: COVID-19; SARS-CoV-2; bioinformatics; metagenomics; virus discovery.
 
Back
Top Bottom